Study of Sunobinop on Craving in Alcohol Use Disorder
Completed · Phase 2 · Has a placebo group
Conditions studied: Alcohol Use Disorder
In brief
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol craving in subjects with moderate to severe alcohol use disorder and these subjects are seeking treatment.
Key facts
- Study ID
- NCT06545929
- Run by
- Knoa Pharma LLC
- People needed
- 40
- Starts
- 2025-01-28
- Expected to finish
- 2025-07-14
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ohio Clinical Trials — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.